FIELD: medicine.
SUBSTANCE: method involves introducing such mononuclear cells of donor umbilical cord blood into patient blood which have a set of antigens HLA-A, HLA -B, HLA-DR, differing from a set of antigens of HLA-A, HLA -B, HLA-DR, with at least four antigens. The quantity of introduced cells is equal to 2,5х106-10х106 cells/kg of body weight per day. The mononuclear donor umbilical cord blood cells introduction course is 2-10 times long with 10-60 days long pauses. When introducing smaller mononuclear umbilical cord blood cells dozes, in comparison to known ones, normalization of clinical biochemical parameters is achieved.
EFFECT: enhanced effectiveness in reducing hepatitis virus copies in blood and toxic or pathological immune reactions.
3 cl,1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING ISCHEMIC CARDIAC DISEASE, OR MYOCARDIAL INFARCTION AND ITS AFTEREFFECTS, OR CEREBRAL ISCHEMIA INDUCED BY ATHEROSCLEROSIS OR ACUTE DYSFUNCTION OF CEREBRAL CIRCULATION, AND ITS AFTEREFFECTS, OR ATHEROSCLEROSIS-INDUCED ISCHEMIA OF INFERIOR LIMBS | 2005 |
|
RU2284190C1 |
| METHOD OF TREATING CHRONIC INFLAMMATORY DISEASES ACCOMPANIED BY IMMUNE DEFICIENCIES | 2012 |
|
RU2522972C2 |
| COMPOSITION FOR TREATING HEPATITIS C AND METHOD OF TREATING HEPATITIS C | 2010 |
|
RU2447899C2 |
| APPLICATION OF PROPAGATED POPULATIONS OF HEMATOPOIETIC STEM CELLS/PROGENITOR CELLS | 2016 |
|
RU2747728C2 |
| METHOD OF TREATING POSTTRAUMATIC ENCEPHALOPATHY | 2009 |
|
RU2413523C2 |
| METHOD FOR PREPARING CELLS FOR REPLACEMENT CELL THERAPY OF HEPATIC PATHOLOGY | 2012 |
|
RU2510276C1 |
| METHOD OF TREATING MENTAL AND NEURAL DISORDERS | 2009 |
|
RU2413524C1 |
| METHODS OF TREATING EPSTEIN-BARR ASSOCIATED LYMPHOPROLIFERATIVE DISEASES WITH THE HELP OF T-CELL THERAPY | 2016 |
|
RU2720245C2 |
| METHOD OF EARLY MOLECULAR-BIOLOGICAL DIAGNOSIS OF MALIGNANT GROWTHS AND AMYOTROPHIC LATERAL SCLEROSIS | 2018 |
|
RU2706714C1 |
| AGENT FOR STEM CELL ACTIVATION | 2004 |
|
RU2272810C2 |
